Exploring the Disruptive Force of 3D Printing in Pharmaceuticals
N D Vijaya Lakshmi, Editor, Pharma Focus America
Welcome to the third edition of Pharma Focus America, where we delve into the intricate world of Pharmaceuticals, presenting insightful articles and expert interviews that provide a unique Industry perspective. Our spotlight theme, "Revolutionizing Drug Manufacturing with 3D Printing," offers key insights from influential figures shaping this transformation narrative in the Pharma Industry. We hope that the third edition of Pharma Focus America Magazine serves as a valuable resource for Pharmaceutical industry professionals globally.
Anna Worsley, CEO, FABRX-AI, Alvaro Goyanes, Co-Founder and Director, FABRX, Hannah Watton, Account Manager, FABRX. In this edition, we delve into the pioneering force that is pharmaceutical 3D printing—an innovation that extends its influence from personalized medicine to the intricacies of clinical trial workflows. This article offers a comprehensive overview, providing valuable insights into 3D printing as a pharmaceutical manufacturing tool and exploring its transformative impact on the field.
Introducing a new element in this edition, we proudly present the "Book Interview" featuring a comprehensive exploration into Clinical Trial Project Management. Authored by Ashok Kumar Peepliwa, Associate Professor at the School of Pharmaceutical Management, IIHMR University, and this book provides a detailed overview of the intricacies involved in conducting clinical trials on a global scale. Navigating the regulatory regimes of various nations, Peepliwa's guide offers a comprehensive understanding of the challenges associated with clinical trial management, from country-specific regulatory dossier submission to final study report preparation, all in compliance with ICH-GCP standards. This addition adds a valuable dimension to our exploration of pharmaceutical innovations.
We are pleased to present the expert panel discussion on "Next-Generation Vaccines," featuring Aaron B. Cowley, Chief Scientific Officer at ReciBioPharm; Patrick Thiaville, Chief Technology Officer at Exothera; and Daniel Kavanagh, Senior Scientific Advisor in Gene Therapy at WCG IRB. Together, they explore the future landscape of nextgeneration vaccines, providing insights into discovering and developing manufacturing processes for enzymes, live biotherapeutics, and advancements in clinical manufacturing and infrastructure design.
Finally, we are honoured to present an expert interview with Dr. Courtney Noah, VP, BIOVIT. Explore the world of liquid biopsy research with insights from her, offering a glimpse into the advancements shaping disease detection, diagnosis, and treatment.
Thank you for being a vital part of the Pharma Focus America community. We eagerly anticipate the continued exchange of ideas and knowledge, as together, we navigate the ever-evolving global Pharmaceutical landscape.
If you have a perspective, an idea, or a story to share, we welcome your voice in our upcoming issues. Whether it's an article that sheds light on emerging trends, an interview with a thought leader, or a unique insight into the Pharmaceutical ecosystem, your wisdom can serve as a guiding beacon for others on their pharmaceutical journey. We want to hear from you via email: [email protected]
Thank you for joining us on this exploration of Pharmaceutical innovations in Pharma Focus America.
Stay Engaged for Exclusive Insights in Upcoming Editions!
Author Bio
N D Vijaya Lakshmi, Editor, Pharma Focus America
